| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Orchestra BioMed Holdings, Inc. | General Manager and Senior Vice President, Focal Therapies | Common Stock, par value $0.0001 per share ("Common Stock") | 42,000 | $21,600 | $1.08 | 08 May 2024 | Direct |
| Orchestra BioMed Holdings, Inc. | General Manager and Senior Vice President, Focal Therapies | Stock Option (Right to Buy) | 33,000 | 08 May 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OBIO | Orchestra BioMed Holdings, Inc. | 08 May 2024 | 2 | $0 | 4 | General Manager and Senior Vice President, Focal Therapies | 10 May 2024, 17:23 |
| OBIO | Orchestra BioMed Holdings, Inc. | 19 Sep 2023 | 0 | $0 | 3 | Title: General Manager and Senior Vice President, Focal Therapies Exhibit 24 - Power of Attorney | 29 Sep 2023, 20:33 |